Beta Bionics, Inc.

NASDAQ:BBNX

Medical - Equipment & Services

Healthcare
$14.33 +3.18%

+$0.42 today

Market cap
$644.70M
Beta
3.39
P/E (TTM)
-9.1
EPS (TTM)
-$1.50
52W Low $8.80High $32.71

Volume 1.38M

Average 0.99M

BBNX Other Non-Cash Items

Other non-cash adjustments that reconcile net income to operating cash flow.

Beta Bionics, Inc.NASDAQ: BBNX

Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026

Other non-cash items declines year over year

Q1 FY2026 other non-cash items of $200K fell 98.3% year over year, in line with the -97.8% change in trailing-twelve-month other non-cash items. Sequentially, it fell 78.7% from the prior quarter.

Context

  • Other non-cash items amounted to 12.0% of revenue in FY2025, down 3.3 pp from a year earlier.
  • Other non-cash items increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -98.3% toward the trailing-twelve-month pace of -97.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$200K-78.7% QoQ
Last fiscal yearDec 2025
$12.01M+20.5% YoY
LTMMar 2026
$463K-97.8% YoY
Other Non-Cash Items past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-98.3%——
1 year+20.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Non-Cash Items history

USD · from the cash flow

Latest · FY2025
12.01M USD
Year-over-year change
+20.5%

Other Non-Cash Items vs competitors

How BBNX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other non-cash items is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -97.8% is the 5th highest of 7, against a peer median of -14.7%.
  • Other non-cash items amounts to 0.4% of revenue for BBNX, versus a peer median of 3.2%.
BBNX Competitors
Other Non-Cash Items for BBNX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVONovo Nordisk A/SLTM Jun 2026DKK 38.4B DKK+48.1%—11.7%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$136.99M USD-1139.7%——
MMEDMiniMed Group, Inc. Common StockLTM Jul 2026$132M USD—+55.1%4.1%
MNKDMannKind CorporationLTM Mar 2026$106.69M USD+550.7%+40.1%29.6%
DXCMDexCom, Inc.LTM Jun 2026$71.8M USD+146.7%—1.4%
TNDMTandem Diabetes Care, Inc.LTM Mar 2026$22.77M USD-77.4%+30.4%2.2%
PODDInsulet CorporationLTM Jun 2026$5.7M USD-104.0%+111.2%0.2%
BBNXBeta Bionics, Inc.LTM Mar 2026$463K USD-97.8%—0.4%
Peer median (excluding BBNX) —-14.7%+47.6%3.2%

Competitors are the stored peer set for BBNX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(64.75M)(44.1M)(54.76M)(73.2M)
Depreciation & Amortization2.09M2.09M2.28M2.88M
Deferred Income Tax0000
Stock-Based Compensation6.1M5.66M6.38M16.38M
Change in Working Capital(2.79M)(6.36M)(12.15M)(8.99M)
Accounts Receivables0(4.49M)(7.62M)(5.16M)
Inventory0(1.19M)(11.44M)(9.88M)
Accounts Payables(77K)716K1.52M2.1M
Other Working Capital(2.71M)(682K)5.39M3.95M
Other Non-Cash Items(854K)10.27M9.96M12.01M
Operating Cash Flow(60.21M)(32.45M)(48.27M)(50.93M)
Capital Expenditures(772K)(402K)(3.4M)(5.3M)
Acquisitions (Net)0000
Purchases of Investments0(69.3M)(72.13M)(327.51M)
Sales of Investments0072M170M
Other Investing Activities3K(69.29M)50K0
Investing Cash Flow(769K)(69.69M)(3.48M)(162.81M)
Debt Repayment0000
Common Stock Issued389K29K55.62M214.87M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities389K101.03M00
Financing Cash Flow56.78M101.03M55.62M214.87M
Effect of Forex Changes0000
Net Change in Cash(4.2M)(1.11M)3.87M1.14M
Free Cash Flow(60.98M)(32.85M)(51.67M)(56.22M)

Beta Bionics, Inc.

NASDAQ:BBNX

Intrinsic Alpha fair value

Locked

Current Price

$14.33

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.